Synergene Active Ingredients Private Limited
incorporated in 2006, is a manufacturer and supplier of Active Pharmaceutical Ingredients (APIs), Intermediates and Personal care ingredients.
The therapeutic segments of focus include Anti fungal, Anti depressant, Anti migraine, Anti hypertensive, Anti glaucoma, Anti histamine, Anti biotic, Analgesic, Premature Ejaculation and UV filters.
Synergene is one of the leading manufacturers in the world for Terbinafine Hydrochloride, Fluconazole, Voriconazole, Losartan Potassium and Escitalopram Oxalate. It has CEP for the products, Terbinafine Hydrochloride, Fluconazole, Voriconazole, Losartan Potassium and Ambroxol Hydrochloride. Synergene has been granted process patents for Luliconazole, Dapoxetine Hydrochloride and Escitalopram Oxalate.
Synergene operates three cGMP-compliant manufacturing facilities across Hyderabad and Visakhapatnam, meeting global infrastructure and quality standards. Following the strategic acquisition of Jaahnavee Life Sciences (Visakhapatnam) in 2018, the company further expanded in 2023 by launching “Synac Pharmaceuticals” to produce active ingredients dedicated to the cosmetics and personal care industry.
